GLP-1 drugs list: brand names, generics, manufacturers, and prices. Learn which GLP-1 medications are FDA-approved for weight loss and diabetes.
A GLP-1 drugs list includes prescription medications that mimic the hormone glucagon-like peptide-1. These drugs are primarily approved for type 2 diabetes and chronic weight management. The best-known names are Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity, Victoza, and Rybelsus.
GLP-1 medications are not available over the counter in the United States. A healthcare professional must prescribe them, and they are intended for use alongside diet and exercise.
GLP-1 drugs are synthetic versions of a gut hormone that helps regulate blood sugar and appetite. They work by binding to GLP-1 receptors, which increases insulin release when blood sugar is high, slows stomach emptying, and reduces hunger signals in the brain. Most GLP-1 drugs are injectables given daily or weekly. One oral option, Rybelsus, is taken as a daily tablet.
GLP-1 Medication Names List
The following table provides a complete GLP-1 medication names list, including brand names, generic names, manufacturers, and approved uses. This list covers FDA-approved products as of 2025.
| Brand Name | Generic Name | Manufacturer | Approved Use | Form |
|---|---|---|---|---|
| Ozempic | semaglutide | Novo Nordisk | Type 2 diabetes | Weekly injection |
| Wegovy | semaglutide | Novo Nordisk | Weight loss | Weekly injection |
| Rybelsus | semaglutide | Novo Nordisk | Type 2 diabetes | Daily oral tablet |
| Mounjaro | tirzepatide | Eli Lilly | Type 2 diabetes | Weekly injection |
| Zepbound | tirzepatide | Eli Lilly | Weight loss | Weekly injection |
| Trulicity | dulaglutide | Eli Lilly | Type 2 diabetes | Weekly injection |
| Victoza | liraglutide | Novo Nordisk | Type 2 diabetes | Daily injection |
| Saxenda | liraglutide | Novo Nordisk | Weight loss | Daily injection |
| Byetta | exenatide | AstraZeneca | Type 2 diabetes | Twice-daily injection |
| Bydureon | exenatide | AstraZeneca | Type 2 diabetes | Weekly injection |
| Adlyxin | lixisenatide | Sanofi | Type 2 diabetes | Daily injection |
Mounjaro is a frequent search term in the GLP-1 drugs list. Mounjaro contains tirzepatide, which is a dual GLP-1 and GIP receptor agonist. It is FDA-approved for type 2 diabetes, and the same active ingredient is approved for weight loss under the brand name Zepbound.
GLP-1 Drug Names for Weight Loss
Not every GLP-1 medication is approved for weight loss. The FDA has approved three GLP-1 drugs specifically for chronic weight management:
- Wegovy (semaglutide) – weekly injection
- Zepbound (tirzepatide) – weekly injection
- Saxenda (liraglutide) – daily injection
Ozempic and Mounjaro are sometimes prescribed off-label for weight loss, but that is not their approved indication. GLP-1 drug names for weight loss should not be confused with over-the-counter diet pills, which are not the same class of medication.
GLP-1 Drugs List Price
The cost of GLP-1 drugs in the United States is high, especially without insurance. The table below shows approximate monthly cash prices for common GLP-1 medications. Actual prices vary by pharmacy, location, and dose.
| Drug | Typical Monthly Cash Price | Notes |
|---|---|---|
| Ozempic | $900–$1,000 | Weekly injection |
| Wegovy | $1,300–$1,500 | Weight loss indication |
| Mounjaro | $1,000–$1,100 | Dual GLP-1/GIP agonist |
| Zepbound | $1,000–$1,200 | Weight loss indication |
| Trulicity | $900–$1,000 | Weekly injection |
| Victoza | $700–$900 | Daily injection |
| Saxenda | $1,200–$1,400 | Daily injection |
| Rybelsus | $900–$1,000 | Oral tablet |
Insurance coverage for GLP-1 drugs varies widely. Some plans cover them for diabetes but not for weight loss. Manufacturer savings cards can reduce out-of-pocket costs for eligible patients. For cash-paying patients, it can help to check the walmart cash price drug list to compare retail pharmacy prices.
Many people also search for compounded versions or glp-1 research peptides for sale as lower-cost alternatives. Compounded GLP-1 medications are not FDA-approved, and research peptides are sold for laboratory use only, not for human consumption.
GLP-1 Drugs List Manufacturer
The GLP-1 market is dominated by a few large pharmaceutical companies. Knowing the manufacturer can help you understand which drugs are related and how they might be priced or covered.
- Novo Nordisk – makes semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Victoza, Saxenda).
- Eli Lilly – makes tirzepatide (Mounjaro, Zepbound) and dulaglutide (Trulicity).
- AstraZeneca – makes exenatide (Byetta, Bydureon).
- Sanofi – makes lixisenatide (Adlyxin).
Novo Nordisk and Eli Lilly together account for the majority of GLP-1 prescriptions in the United States. The GLP-1 drugs list manufacturer information is important when comparing insurance formularies and patient assistance programs.
Research Peptides and Related Compounds
Outside of FDA-approved medications, there is growing interest in research peptides that target similar pathways. These are not approved for human use and are sold strictly for laboratory research.
For example, retatrutide is an investigational triple agonist that some people mistakenly call a GLP-3. If you are wondering is retatrutide a glp-3, the answer is no—retatrutide is a GLP-1/GIP/glucagon receptor agonist, and it is not FDA-approved.
Similarly, tirz glp-1 is a common shorthand for tirzepatide, the active ingredient in Mounjaro and Zepbound. Some researchers also explore sermorelin and glp-1 together in preclinical settings, but there is no clinical data on the safety or effectiveness of that combination in humans.
Safety and Medical Guidance
GLP-1 drugs can cause side effects, especially when starting treatment. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. More serious risks include pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumors.
GLP-1 drugs are not appropriate for everyone. People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not use them. Pregnant or breastfeeding women should talk to their doctor before starting any GLP-1 medication.
Always consult a licensed healthcare professional before using any GLP-1 drug. This article is for informational purposes only and does not constitute medical advice.
Frequently Asked Questions
What is the strongest GLP-1 drug for weight loss?
Tirzepatide (Mounjaro and Zepbound) is generally considered the most effective GLP-1-based drug for weight loss, with clinical trials showing greater average weight loss than semaglutide. However, individual results vary, and all GLP-1 drugs require a prescription and medical supervision.
How much do GLP-1 drugs cost without insurance?
Most GLP-1 drugs cost between $900 and $1,500 per month without insurance in the United States. Manufacturer savings cards and patient assistance programs can reduce out-of-pocket costs for eligible patients.
Is Ozempic a GLP-1 drug?
Yes, Ozempic is a GLP-1 receptor agonist. Its active ingredient is semaglutide, and it is FDA-approved for type 2 diabetes. Wegovy, a higher-dose version of semaglutide, is approved for weight loss.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.